Bone Disorders Flashcards
Treatment of nutritinal osteomalacia & rickets is……, treatment of renal rickets is……
Ca+vit D (IM in malapsorption)
Ca+calcitriol or alfacalcidiol
List drugs causing osteoporosis
Heparin, aluminum antacids, phenytoin, PPI, glucocorticoids
1st line treatment of osteoporosis is……
Bisphosphonates OR denosumab
Describe mechanism of action of bisphosphonates
Inc osteoclastoc apoptosis & inhibit cholesterol pathway important for osteoclastic function. This result in a small inc in bone mass & dec risk of fractures. Beneficial effects of alendronate persist over several yrs of therapy (but discontinuatio results in a gradual loss of effects).
List indications of bisphosphonates
- Hypercalcemia associated with malignancy
- Osteoporosis (inc bone mineral density)
- Paget’s disease of bone, dec bone turnover
List adverse reactions of bisphosphonates
- Gastric & esophageal irritation (take with a full glass of water while sitting upright for 30 min) CI: peptic ulcer & esophageal motility disorders
- Osteonecrosis of jaw
- Given cautiously in renal impairment
Mechanism of action & use of denosumab
Mab against RANKL inhibit osteoclast formation & function —> inhibit bone resorption
Used in postmenoposal osteoporosis in women at high risk of fracture & those intolerant or unresponsive to other osteoporosis therapies.
SC injection every 6 mons
List adverse effects of denosumab
- Inc risk of infections
- Dermatological reactions
- Hypocalcemia, osteonecrosis of jaw & atypical features.
Mechanism, uses & AEs of calcitonin
M, reduces bone resorption but less effective than bisphosphonates & relief of pain associated with osteoporotic fracture.
U, Paget’s disease & hypercalcemia
AE,
1. N&V& bad tase
2. Facial flushing, swelling of hands
3. Runny nose, nasal bleeding & nasal irritation (with nasal spray)
……is calcitonin preparation with high t1/2 & potency
Salmon calcitonin
Mechanism of action & indications of estrogen
-inhibit bone resorption induced by parathyroid hormone
-Used in Prevention & treatment of osteoporosis in post-menopausal women (may inc risk of cancer)
Mechanism of action & adverse effects of raloxifene
Selective estrogen receptor modulator (partial agonist) with effects similar to estrogen on bone (inhibit bone resorption) but not on brest or uterus (no risk of cancer)
AEs: hot flashes, sweating, leg cramps, thrombophlebitis & thromboembolism.(CI: venous thrombo-embolism)
Mechanism of action & indications of SERM
Bazedoxifene: SERM, estrogen-like effects on bone (inc bone density) and lipids (dec LDL); antiestrogenic in uterus & breast (reduces risk of endometrial hyperplasia which can occur with conjugated estrogens)
Used in osteoporosis & menopausal vasomotor symptoms.
Mechanism of action of romosozumab
Sclerostin inhibitor
Mechanism of action & indications of teriparatide
Promote bone formation by stimulating osteoblastic activity
Reserved for patients with high risk of fractures who have failed or cannot tolerate other therapies.